These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33036570)

  • 61. Thoracic imaging tests for the diagnosis of COVID-19.
    Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD
    Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis.
    Gao J; Zheng P; Fu H
    PLoS One; 2013; 8(5):e64915. PubMed ID: 23741419
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.
    Tavares AM; Fronteira I; Couto I; Machado D; Viveiros M; Abecasis AB; Dias S
    PLoS One; 2017; 12(9):e0185526. PubMed ID: 28957400
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Maintaining robust HIV and tuberculosis services in the COVID-19 era: A public health dilemma in Zimbabwe.
    Mukwenha S; Dzinamarira T; Mugurungi O; Musuka G
    Int J Infect Dis; 2020 Nov; 100():394-395. PubMed ID: 32979586
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois.
    Udoakang AJ; Djomkam Zune AL; Tapela K; Nganyewo NN; Olisaka FN; Anyigba CA; Tawiah-Eshun S; Owusu IA; Paemka L; Awandare GA; Quashie PK
    Front Immunol; 2023; 14():1104828. PubMed ID: 36776887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS Med; 2020 Sep; 17(9):e1003293. PubMed ID: 32941437
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Linking private, for-profit providers to public sector services for HIV and tuberculosis co-infected patients: A systematic review.
    Hudson M; Rutherford GW; Weiser S; Fair E
    PLoS One; 2018; 13(4):e0194960. PubMed ID: 29634772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV and COVID-19: review of clinical course and outcomes.
    Barbera LK; Kamis KF; Rowan SE; Davis AJ; Shehata S; Carlson JJ; Johnson SC; Erlandson KM
    HIV Res Clin Pract; 2021 Aug; 22(4):102-118. PubMed ID: 34514963
    [No Abstract]   [Full Text] [Related]  

  • 69. Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016, and impact of HIV co-infection and prior drug exposure: A systematic review and meta-analysis.
    Eshetie S; Gizachew M; Alebel A; van Soolingen D
    PLoS One; 2018; 13(3):e0194675. PubMed ID: 29554144
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
    Diriba K; Awulachew E; Getu E
    Eur J Med Res; 2020 Sep; 25(1):39. PubMed ID: 32887660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.
    Di Maria E; Latini A; Borgiani P; Novelli G
    Hum Genomics; 2020 Sep; 14(1):30. PubMed ID: 32917282
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV.
    Castel AD; Wilbourn B; Magnus M; Greenberg AE
    AIDS Rev; 2020; 22(3):133-142. PubMed ID: 33118529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia.
    Kalichman SC; Eaton LA; Berman M; Kalichman MO; Katner H; Sam SS; Caliendo AM
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):66-72. PubMed ID: 32530862
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Undiagnosed Pulmonary Tuberculosis (TB) and Coronavirus Disease 2019 (COVID-19) in Adults Dying at Home in a High-TB-Burden Setting, Before and During Pandemic COVID-19: An Autopsy Study.
    Sabet N; Omar T; Milovanovic M; Magajane T; Mosala M; Moloantoa T; Kato-Kalule N; Semedo LV; Swanepoel F; Wallis C; Abraham P; Lebina L; Variava E; Martinson N
    Clin Infect Dis; 2023 Aug; 77(3):453-459. PubMed ID: 37041678
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China.
    Guo W; Ming F; Feng Y; Zhang Q; Mo P; Liu L; Gao M; Tang W; Liang K
    J Int AIDS Soc; 2020 Jul; 23(7):e25568. PubMed ID: 32697865
    [No Abstract]   [Full Text] [Related]  

  • 77. Outcomes Among HIV-Positive Patients Hospitalized With COVID-19.
    Karmen-Tuohy S; Carlucci PM; Zervou FN; Zacharioudakis IM; Rebick G; Klein E; Reich J; Jones S; Rahimian J
    J Acquir Immune Defic Syndr; 2020 Sep; 85(1):6-10. PubMed ID: 32568770
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Population risk factors for COVID-19 deaths in Nigeria at sub-national level.
    Hassan Z; Hashim MJ; Khan G
    Pan Afr Med J; 2020; 35(Suppl 2):131. PubMed ID: 33193946
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features.
    Iannarella R; Lattanzi C; Cannata G; Argentiero A; Neglia C; Fainardi V; Pisi G; Esposito S
    Acta Biomed; 2020 Sep; 91(3):e2020032. PubMed ID: 32921726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.